HIV molecular immunology database

 

Search the Epitope Variant and Escape Mutation Database

Help


Found 1 matching record:

Displaying record number 55237

HXB2 Location  Gag(93-101)   Gag Epitope Map
View variants at this location
Epitope EIKDTKEAL   Epitope Alignment
Variants
EvKDTKEAL   observed variant
dvKDTKEAL   observed variant
EIlDTKEAL   observed variant
dIKDTKEAL   reversion
Species (MHC/HLA human(B8)

Variant Details

Showing all: 4 variant(s).


Variant ID.  795
Epitope Seq.  EIKDTKEAL
Variant Seq.  EvKDTKEAL
Mutations I/V
Epitope Location I2V
HXB2 Location I94V
Mutation Type OV: observed variant
Variant Subtype B
Method Sequence
Note Patient was superinfected with three strains, B1, B2 and CRF01_AE. This was the infecting variant in B1.


Variant ID.  797
Epitope Seq.  EIKDTKEAL
Variant Seq.  dvKDTKEAL
Mutations E/D I/V
Epitope Location E1D I2V
HXB2 Location E93D I94V
Mutation Type OV: observed variant
Variant Subtype B
Method Sequence
Note Patient was superinfected with three strains, B1, B2 and CRF01_AE. This was the infecting variant in B2 and it did not change over time.


Variant ID.  798
Epitope Seq.  EIKDTKEAL
Variant Seq.  EIlDTKEAL
Mutations K/L
Epitope Location K3L
HXB2 Location K95L
Mutation Type OV: observed variant
Variant Subtype CRF01_AE
Method Sequence
Note Patient was superinfected with three strains, B1, B2 and CRF01_AE. This was the infecting variant in CRF01_AE and it did not change over time.


Variant ID.  2258
Epitope Seq.  EIKDTKEAL
Variant Seq.  dIKDTKEAL
Mutations E/D
Epitope Location E1D
HXB2 Location E93D
Mutation Type R: reversion
Variant Subtype B
Method Sequence
Note Patient was superinfected with three strains, B1, B2 and CRF01_AE. This reversion variant developed in B1 to include 83% of the viruses within 4 years.

References

Kozaczynska2007 Karolina Kozaczynska, Marion Cornelissen, Peter Reiss, Fokla Zorgdrager, and Antoinette C. van der Kuyl. HIV-1 Sequence Evolution In Vivo after Superinfection with Three Viral Strains. Retrovirology, 4:59, 2007. PubMed ID: 17716368. Show all entries for this paper.


Questions or comments? Contact us at immuno@lanl.gov
 
Managed by Triad National Security, LLC for the U.S. Department of Energy’s National Nuclear Security Administration
Copyright © 2022 Triad National Security, LLC | Disclaimer/Privacy

Dept of Health & Human Services Los Alamos National Institutes of Health